PremiumOne fifth of management positions in listed companies are in accumulation

28 directors accumulate positions in several companies listed on the Lisbon stock exchange. Accumulation is permitted by market rules and points to the cross-cutting nature of some economic groups in Portugal, which are shareholders in several companies. Small shareholders' association argues that executive directors should not accumulate positions outside their business group.

Almost a fifth of management positions at companies listed in Portugal are in accumulation. A total of 28 directors occupy 67 positions in a universe of 370 listed in Portugal. These managers occupy executive and non-executive positions in more than 50% of the companies that trade on Euronext Lisbon: in 20 of the 38 companies in the two Portuguese stock indexes.

These values ​​contrast with those revealed in the last study carried out in Portugal on the accumulation of positions. In a report related to 2014, but published in March 2016, the CMVM revealed that in "only 20 of the 422 positions in the management bodies were held by directors who did not exercise functions in any other company". In other words, about 95% of the directors of listed companies in 2014 held positions in other companies.

One explanation for the lower percentage found by Jornal Económico (JE) is that this analysis only focused on the accumulation of positions in listed companies, leaving out companies outside the Lisbon stock exchange.

Content reserved for subscribers. To read the full version, go to here to the JE Reader

Recommended

PremiumLuciano Huck: Another television star who can't resist falling into the cauldron of politics

The popular presenter of Globo has been feeding the taboo of availability to run for president of Brazil for three years, being able to face Jair Bolsonaro in 2022. A lunch with Sérgio Moro and various supports in the ongoing municipal elections increased speculation.

PremiumCovid-19: What to expect from life after vaccines

Exciting news in clinical trials of Covid-19 vaccines offer hope for economic recovery, but there are reasons to confine over-optimism. Since vaccination is a complicated logistics process and one that will take time to achieve group immunity, no one expects tourism to return to pre-Covid levels anytime soon. It is certain that teleworking will continue to be more common than before, but opinions are divided as to the healing of the crisis.

PremiumThe vaccine and the bags: Arm wrestling between the injection of optimism and the immediate reality

After the euphoric reaction and gains in scholarships to the news of the 90% efficacy of the vaccine from Pfizer and BioNTech last week, the test results of Moderna were received with more restraint, despite superior efficacy and advantages in terms of storage. The effect of Joe Biden's election to the White House, which had helped gains last week, is already diluted, as is the surprise factor about the vaccine. Conversely, the increase in the number of infections and deaths in several regions should lead to further restrictions and permanent economic damage, concerns that overlap with optimism about the vaccine.
Comments